Bupivacaine Injection, Solution
Product Images NDC 0409-3613

6 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bupivacaine (NDC 0409-3613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Bupivacaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)
Chemical structure diagram of Bupivacaine Hydrochloride in Dextrose, showing the molecular composition relevant to the active ingredient in Bupivacaine Spinal 7.5 mg/mL injection solution for subarachnoid use.*
FDA Label Image

Structural Formula Dextrose (Bupivacaine 03)

Structural Formula Dextrose (Bupivacaine 03)
Chemical structure diagram of the dextrose component in Bupivacaine Spinal injection, depicting the glucose ring with hydroxyl groups and a water molecule (H2O) associated.*
FDA Label Image

Hospira Logo (Bupivacaine 04)

FDA Label Image

Principal Display Panel (2 mL Ampule Label)

Principal Display Panel (2 mL Ampule Label)
Label for Bupivacaine Spinal Injection, Solution, 7.5 mg/mL (15 mg/2 mL) in Dextrose 8.25% by Hospira, Inc. The label indicates a 2 mL package with the National Drug Code 0409-3613-11, including identification text and a barcode. It specifies the product is for subarachnoid use with the proprietary and generic names displayed prominently.*
FDA Label Image

Principal Display Panel (10 Ampule Carton Label)

Principal Display Panel (10 Ampule Carton Label)
Label for Bupivacaine Spinal 7.5 mg/mL sterile hyperbaric solution for spinal anesthesia injection. Contains 10 single-dose 2 mL ampuls. The solution includes Bupivacaine HCl 0.75% in Dextrose 8.25%. Manufactured in Switzerland and distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.